Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Necrosis01:16

Necrosis

7.4K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
7.4K
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.8K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.8K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

1.0K
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
Rh Blood Group01:19

Rh Blood Group

4.5K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
4.5K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.9K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.9K
Hematopoiesis01:21

Hematopoiesis

10.2K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
10.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of multicenter consensus care plans for immunosuppression after pediatric liver transplant: Reducing variability, creating comparative efficacy opportunities.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

AASLD AST NASPGHAN Practice Guideline on pediatric liver transplantation: Post-transplant management.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

Can Follow-up Liver Biopsies With Subsequent Protocolized Immunosuppression Intensification Reverse Long-term Rejection and Fibrosis After Pediatric Liver Transplantation?

Transplantation·2026
Same author

Meeting Report: The 2025 Annual Meeting of the Society of Pediatric Liver Transplantation.

Transplantation·2026
Same author

Living donor liver transplant is associated with lower hospitalization costs than deceased donor liver transplant: A multicenter cohort study of young children transplanted for biliary atresia.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Liver transplantation for primary sclerosing cholangitis in children versus young adults.

Surgery·2026
Same journal

Corrigendum to "Nuances in ATP7B Genetic Testing and Interpretation in India" [J Clin Exp Hepatol 16 (1) (2026) 103205].

Journal of clinical and experimental hepatology·2026
Same journal

Hepatic Melioidosis: A State-of-the-Art Review.

Journal of clinical and experimental hepatology·2026
Same journal

Overlap Syndromes and Associated Immunoglobulin-G4-Related Liver Diseases.

Journal of clinical and experimental hepatology·2026
Same journal

Redefinition of Fatty Liver Disease: Stigma or Fatphobia?

Journal of clinical and experimental hepatology·2026
Same journal

Relative Adrenal Insufficiency in Decompensated Cirrhosis With Hyponatremia: Disease Severity Marker or Therapeutic Target?

Journal of clinical and experimental hepatology·2026
Same journal

Liver Transplant Outcomes in Patients With Transjugular Intrahepatic Portosystemic Shunt: A Retrospective Cohort Study With Propensity Score Analysis.

Journal of clinical and experimental hepatology·2026
See all related articles

Related Experiment Video

Updated: Apr 16, 2026

Isolation of Neonatal Extrahepatic Cholangiocytes
07:54

Isolation of Neonatal Extrahepatic Cholangiocytes

Published on: June 5, 2014

11.0K

Neonatal hemochromatosis.

Amy G Feldman1, Peter F Whitington1

  • 1Department of Pediatrics, Feinberg Medical School of Northwestern University, Ann and Robert H. Lurie Children's Hospital of Chicago, 225 East Chicago Avenue, Box 57, Chicago, IL 60611-2605, United States.

Journal of Clinical and Experimental Hepatology
|March 11, 2015
PubMed
Summary
This summary is machine-generated.

Neonatal hemochromatosis (NH) is caused by gestational alloimmune liver disease (GALD), where maternal antibodies attack fetal liver cells. Early identification of GALD is crucial for effective treatment in future pregnancies.

Keywords:
FcRn, fragment receptorGALD, gestational alloimmune liver diseaseIVIG, intravenous immunoglobulinIgG, immunoglobulin GNH, neonatal hemochromatosisNTBI, non-transferrin bound ironacute liver failurecomplementgestational alloimmune liver diseaseimmunoglobulin

More Related Videos

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

5.8K
Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.6K

Related Experiment Videos

Last Updated: Apr 16, 2026

Isolation of Neonatal Extrahepatic Cholangiocytes
07:54

Isolation of Neonatal Extrahepatic Cholangiocytes

Published on: June 5, 2014

11.0K
Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

5.8K
Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

2.6K

Area of Science:

  • Immunology
  • Hepatology
  • Neonatology

Background:

  • Neonatal hemochromatosis (NH) presents as severe newborn liver disease with iron overload.
  • Gestational alloimmune liver disease (GALD) is the primary cause of fetal liver injury leading to NH.
  • GALD involves maternal IgG antibodies targeting fetal liver antigens, activating complement and causing hepatocyte death.

Purpose of the Study:

  • To elucidate the pathophysiology of GALD as the cause of NH.
  • To highlight the clinical presentations of GALD, including fetal demise and neonatal liver failure.
  • To emphasize the importance of recognizing GALD for timely intervention.

Main Methods:

  • Review of existing literature on NH and GALD.
  • Analysis of the immunological mechanisms in GALD.
  • Clinical case correlation of GALD manifestations.

Main Results:

  • GALD leads to fetal liver injury, resulting in conditions like congenital cirrhosis or acute liver failure.
  • Iron overload and siderosis can be present in infants with GALD.
  • GALD can manifest in fetal demise, stillbirth, and neonatal acute liver failure.

Conclusions:

  • GALD is the established cause of NH, involving maternal-fetal antigen incompatibility.
  • Recognizing GALD is critical for managing affected newborns and improving outcomes in subsequent pregnancies.
  • Prompt diagnosis of GALD enables effective treatment strategies for affected families.